Withings Health Solutions Joins the Novo Nordisk Partner Platform to Support Connected Weight Management
Press Release
Last edit: June 16, 2026
June 10, 2026
As obesity care continues to evolve, Withings Health Solutions brings remote body composition monitoring to digital weight-management programs.
Paris, June 15, 2026 - Withings Health Solutions, a pioneer in connected health devices for remote patient monitoring, today announced it is joining the Novo Nordisk Partner Platform, a curated library of digital health solutions designed to help health companies build and strengthen weight-management programs.
Obesity is one of the most urgent global health challenges of our time, affecting more than one billion people worldwide. It is a serious, chronic and progressive disease that requires long-term management and a comprehensive approach to care. Recent advances in GLP-1 receptor agonist (GLP-1) therapies, a class of medicines that help regulate appetite and food intake, are changing the way obesity is treated and managed, creating new opportunities for more personalized and effective care.
As the use of GLP-1 therapies grows, healthcare providers increasingly require tools that go beyond measuring weight alone. Monitoring body composition, including changes in fat mass and muscle mass, can help provide a more complete picture of patient progress and support better-informed care decisions.
Monitoring That Keeps Up With How Care Has Changed
Weight-management programs have evolved significantly in recent years. Patients require ongoing support throughout their weight-management journey, while care teams need reliable health data that fits naturally into existing workflows. For digital health companies, scalable monitoring solutions that can be deployed quickly and engage patients over the long term are becoming an increasingly important part of program success.
Withings Health Solutions brings more than a decade of experience in connected health and over one million patients monitored globally. Its devices are designed to fit naturally into patients’ daily routines, contributing to sustained engagement, with 93% of users remaining active after 12 months.
"The Novo Nordisk Partner Platform gives digital health companies a direct path to the connected health tools their programs need," said Antoine Pivron, Vice President, Withings Health Solutions. "When devices become part of a patient's daily routine, engagement follows naturally. That is when care teams start receiving the continuous, reliable data they need to make meaningful clinical decisions and support long-term outcomes."
Supporting the Next Generation of Weight Management Programs
The Novo Nordisk Partner Platform brings together digital health solutions that can help digital health companies build comprehensive obesity care pathways, including patient engagement, remote monitoring and long-term disease management.
"Successful obesity care is about more than weight loss—it is about improving health outcomes sustainably. Through the Novo Nordisk Partner Platform, we are bringing together partners that can help digital health companies deliver more personalized, connected care. Withings' expertise in body composition monitoring can add an important dimension to understanding patient progress and supporting long-term obesity management." — Cem Ozenc, Group Vice President, IO Fast, Novo Nordisk
Through the platform, digital health companies can explore available solutions, making it easier to evaluate, implement and scale remote monitoring capabilities within their weight-management programs.
Digital health companies can explore Withings Health Solutions through the platform and initiate discussions regarding implementation and integration. Learn more about the Novo Nordisk Partner Platform.
For media inquiries, please contact:
Europe
Alma Miftari
alma@prlab.co
United States
Kate Kaminsky
withings@120group.com